Latest released contribution from Dr. Piazza Fabrizio on Neurology @GreenJournal

What is the accepted risk between optimizing positive effects and reducing ARIA incidence and severity?

Addressing this question might have a profound impact on the design of more effective drugs and clinical trials, not only from a mere safety perspective but, most importantly, in terms of providing a greater understanding of WHY and HOW immunotherapy drugs work?.;66123